2015
DOI: 10.1016/j.neurobiolaging.2015.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
45
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(50 citation statements)
references
References 31 publications
4
45
1
Order By: Relevance
“…Such correlation has also been observed in aged rodents (Fu et al, 2014; Lim et al, 2015). The first clinical approach has thus consisted in inhibiting the decrease of acetylcholine (ACh) by blocking its degradation by acetylcholinesterase (AChE) in the synaptic cleft (Marighetto et al, 2008).…”
Section: Introductionsupporting
confidence: 63%
“…Such correlation has also been observed in aged rodents (Fu et al, 2014; Lim et al, 2015). The first clinical approach has thus consisted in inhibiting the decrease of acetylcholine (ACh) by blocking its degradation by acetylcholinesterase (AChE) in the synaptic cleft (Marighetto et al, 2008).…”
Section: Introductionsupporting
confidence: 63%
“…As a first step toward such applications, we demonstrated that the dissociated FC profiles of the identified CBF subdivisions are reproducible in rs‐fMRI acquisitions of elderly participants as typically collected in clinical research settings. We expect rs‐fMRI‐based assessments of CBF connectivity to be particularly useful for the study of functional CBF alterations in predementia stages of neurodegenerative disease (Brayda‐Bruno et al, ; Grothe, Ewers, Krause, Heinsen, & Teipel, ; Lim et al, ; Ray et al, ), as well as other neuropsychiatric conditions with cholinergic involvement that are not typically associated with gross neurodegeneration (Grothe et al, ; Perry et al, ; Sarter et al, ).…”
Section: Resultsmentioning
confidence: 99%
“…Second, the loss of cholinergic innervation of cerebral blood vessels in AD may also contribute to brain hypoperfusion. Indeed, disruptions in cholinergic neurotransmission are known to exacerbate cognitive impairments in pre-clinical AD (Lim et al, 2015). Compared to age-matched control subjects, AD patients exhibited greater blood brain barrier disruption (Erickson and Banks, 2013) and elevated expression of receptor for advanced glycation endproducts (RAGE) (Janota et al, 2016), which is essential for the influx of peripheral Aβ into the brain.…”
Section: Aging Of White Matter In Neurodegenerative Diseasesmentioning
confidence: 99%